Global COVID-19 Serology Testing Monthly Market Outlook 2020-2021

1 REPORT OVERVIEW 1

• 1.1 Study Scope 1
• 1.2 Global COVID-19 Total Confirmed Cases 1
• 1.3 Representative Covid-19 Serology Testing Developers 3
  • 1.3.1 Rapid Diagnostic Test (RDT) 4
  • 1.3.2 Enzyme Linked Immunosorbent Assay (ELISA) 5
  • 1.3.3 Neutralization Assay 5
• 1.4 Coronavirus Disease 2019 (Covid-19): Covid-19 Serology Testing Industry Impact 6
  • 1.4.1 How the Covid-19 is Affecting the Covid-19 Serology Testing Industry 7
  • 1.4.2 Market Trends and Covid-19 Serology Testing Potential Opportunities in the COVID-19 Landscape 9
  • 1.4.3 Covid-19 Impact on Key Regions 11
  • 1.4.4 Proposal for Covid-19 Serology Testing Players to Combat Covid-19 Impact 12

2 GLOBAL COVID-19 SEROLOGY TESTING CONSUMPTION 14

• 2.1 Global Covid-19 Serology Testing, Total Demand and Consumption, 2020 by Month 14
• 2.2 Global Covid-19 Serology Testing Consumption, by Key Regions 14
• 2.3 Global Covid-19 Serology Testing Output by Key Countries 15

3 KEY COVID-19 SEROLOGY TESTING DEVELOPERS AND SUPPLIERS 16

• 3.1 Cellex 16
  • 3.1.1 Cellex Company Details 16
  • 3.1.2 Cellex Description and Business Overview 16
  • 3.1.3 Cellex Covid-19 Serology Testing Introduction 16
  • 3.1.4 Cellex Covid-19 Serology Testing Output by Month in 2020 and 2021f 17
• 3.2 Abbott 17
  • 3.2.1 Abbott Company Details 17
  • 3.2.2 Abbott Description and Business Overview 18
  • 3.2.3 Abbott Covid-19 Serology Testing Introduction 18
  • 3.2.4 Abbott Covid-19 Serology Testing Output by Month in 2020 and 2021f 19
• 3.3 Roche 19
  • 3.3.1 Roche Company Details 19
  • 3.3.2 Roche Description and Business Overview 19
  • 3.3.3 Roche Covid-19 Serology Testing Introduction 20
  • 3.3.4 Roche Covid-19 Serology Testing Output by Month in 2020 and 2021f 20
• 3.4 BioMedomics 21
  • 3.4.1 BioMedomics Company Details 21
  • 3.4.2 BioMedomics Description and Business Overview 21
  • 3.4.3 BioMedomics Covid-19 Serology Testing Introduction 22
  • 3.4.4 BioMedomics Covid-19 Serology Testing Output by Month in 2020 and 2021f 22
• 3.5 BD 23
  • 3.5.1 BD Company Details 23
  • 3.5.2 BD Description and Business Overview 23
  • 3.5.3 BD Covid-19 Serology Testing Introduction 24
  • 3.5.4 BD Covid-19 Serology Testing Output by Month in 2020 and 2021f 24
• 3.6 Henry Schein 25
  • 3.6.1 Henry Schein Company Details 25
  • 3.6.2 Henry Schein Description and Business Overview 25
  • 3.6.3 Henry Schein Covid-19 Serology Testing Introduction 25
  • 3.6.4 Henry Schein Covid-19 Serology Testing Output by Month in 2020 and 2021f 26
• 3.7 Safecare Bio-Tech 26
  • 3.7.1 Safecare Bio-Tech Company Details 26
  • 3.7.2 Safecare Bio-Tech Description and Business Overview 27
  • 3.7.3 Safecare Bio-Tech Covid-19 Serology Testing Introduction 27
  • 3.7.4 Safecare Bio-Tech Covid-19 Serology Testing Output by Month in 2020 and 2021f 28
• 3.8 Mayo Clinic Laboratories 28
  • 3.8.1 Mayo Clinic Laboratories Company Details 28
  • 3.8.2 Mayo Clinic Laboratories Description and Business Overview 29
  • 3.8.3 Mayo Clinic Laboratories Covid-19 Serology Testing Introduction 29
  • 3.8.4 Mayo Clinic Laboratories Covid-19 Serology Testing Output by Month in 2020 and 2021f 30
• 3.9 Chembio Diagnostics 31
  • 3.9.1 Chembio Diagnostics Company Details 31
  • 3.9.2 Chembio Diagnostics Description and Business Overview 31
  • 3.9.3 Chembio Diagnostics Covid-19 Serology Testing Introduction 32
  • 3.9.4 Chembio Diagnostics Covid-19 Serology Testing Output by Month in 2020 and 2021f 32
• 3.10 Mount Sinai Laboratory 32
  • 3.10.1 Mount Sinai Laboratory Company Details 32
  • 3.10.2 Mount Sinai Laboratory Description and Business Overview 33
  • 3.10.3 Mount Sinai Laboratory Covid-19 Serology Testing Introduction 33
  • 3.10.4 Mount Sinai Laboratory Covid-19 Serology Testing Output by Month in 2020 and 2021f 34
• 3.11 Ortho Clinical Diagnostics 34
  • 3.11.1 Ortho Clinical Diagnostics Company Details 34
  • 3.11.2 Ortho Clinical Diagnostics Description and Business Overview 35
  • 3.11.3 Ortho Clinical Diagnostics Covid-19 Serology Testing Introduction 35
  • 3.11.4 Ortho Clinical Diagnostics Covid-19 Serology Testing Output by Month in 2020 and 2021f 36
• 3.12 Zhejiang Orient Gene Biotech 36
  • 3.12.1 Zhejiang Orient Gene Biotech Company Details 36
  • 3.12.2 Zhejiang Orient Gene Biotech Description and Business Overview 37
  • 3.12.3 Zhejiang Orient Gene Biotech Covid-19 Serology Testing Introduction 37
  • 3.12.4 Zhejiang Orient Gene Biotech Covid-19 Serology Testing Output by Month in 2020 and 2021f 38
• 3.13 Innovita Biological Technology 38
  • 3.13.1 Innovita Biological Technology Company Details 38
  • 3.13.2 Innovita Biological Technology Description and Business Overview 39
  • 3.13.3 Innovita Biological Technology Covid-19 Serology Testing Introduction 39
  • 3.13.4 Innovita Biological Technology Covid-19 Serology Testing Output by Month in 2020 and 2021f 40
• 3.14 Guangzhou Wondfo Biotech 40
  • 3.14.1 Guangzhou Wondfo Biotech Company Details 40
  • 3.14.2 Guangzhou Wondfo Biotech Description and Business Overview 41
  • 3.14.3 Guangzhou Wondfo Biotech Covid-19 Serology Testing Introduction 42
  • 3.14.4 Guangzhou Wondfo Biotech Covid-19 Serology Testing Output by Month in 2020 and 2021f 42
• 3.15 Guangdong Hecin-Scientific 43
  • 3.15.1 Guangdong Hecin-Scientific Company Details 43
  • 3.15.2 Guangdong Hecin-Scientific Description and Business Overview 43
  • 3.15.3 Guangdong Hecin-Scientific Covid-19 Serology Testing Introduction 43
  • 3.15.4 Guangdong Hecin-Scientific Covid-19 Serology Testing Output by Month in 2020 and 2021f 44
• 3.16 Dynamiker Biotechnology (Tianjin) 44
  • 3.16.1 Dynamiker Biotechnology (Tianjin) Company Details 44
  • 3.16.2 Dynamiker Biotechnology (Tianjin) Description and Business Overview 45
  • 3.16.3 Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Introduction 45
  • 3.16.4 Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Output by Month in 2020 and 2021f 46
• 3.17 ADVAITE 46
  • 3.17.1 ADVAITE Company Details 46
  • 3.17.2 ADVAITE Description and Business Overview 47
  • 3.17.3 ADVAITE Covid-19 Serology Testing Introduction 47
  • 3.17.4 ADVAITE Covid-19 Serology Testing Output by Month in 2020 and 2021f 49

4 NORTH AMERICA 50

• 4.1 North America Covid-19 Serology Testing, Total Demand and Consumption by Country, 2020 and 2021 50
• 4.2 U.S. 51
  • 4.2.1 U.S. COVID-19 Cases 51
  • 4.2.2 U.S. Covid-19 Serology Testing Consumption and Demand 52
  • 4.2.3 Key Covid-19 Serology Testing Approved in U.S. 52
• 4.3 Canada 53
  • 4.3.1 Canada COVID-19 Cases 53
  • 4.3.2 Canada Covid-19 Serology Testing Consumption and Demand 55
  • 4.3.3 Covid-19 Serology Testing in Canada 56
• 4.4 Mexico 57
  • 4.4.1 Mexico COVID-19 Cases 57
  • 4.4.2 Mexico Covid-19 Serology Testing Consumption and Demand 58
  • 4.4.3 Covid-19 in Mexico 58

5 EUROPE 59

• 5.1 Europe Covid-19 Serology Testing, Total Demand and Consumption by Country, 2020 and 2021 59
• 5.2 Italy 60
  • 5.2.1 Italy COVID-19 Cases 60
  • 5.2.2 Italy Covid-19 Serology Testing Consumption and Demand 60
  • 5.2.3 Key Covid-19 Serology Testing Products Approved in Italy 61
• 5.3 Spain 61
  • 5.3.1 Spain COVID-19 Cases 61
  • 5.3.2 Spain Covid-19 Serology Testing Consumption and Demand 62
  • 5.3.3 Covid-19 in Spain 62
• 5.4 France 63
  • 5.4.1 France COVID-19 Cases 63
  • 5.4.2 France Covid-19 Serology Testing Consumption and Demand 64
  • 5.4.3 Key Covid-19 Serology Testing Products Approved in France 64
• 5.5 UK 65
  • 5.5.1 UK COVID-19 Cases 65
  • 5.5.2 UK Covid-19 Serology Testing Consumption and Demand 65
  • 5.5.3 Key Covid-19 Serology Testing Approved in UK 66
• 5.6 Germany 67
  • 5.6.1 Germany COVID-19 Cases 67
  • 5.6.2 Germany Covid-19 Serology Testing Consumption and Demand 68
  • 5.6.3 Key Covid-19 Serology Testing Approved in Germany 68
• 5.7 Belgium 69
  • 5.7.1 Belgium COVID-19 Cases 69
  • 5.7.2 Belgium Covid-19 Serology Testing Consumption and Demand 70
  • 5.7.3 Covid-19 Serology Testing Products Approved in Belgium 71
• 5.8 Netherlands 72
  • 5.8.1 Netherlands COVID-19 Cases 72
  • 5.8.2 Netherlands Covid-19 Serology Testing Consumption and Demand 72
  • 5.8.3 Covid-19 in Netherlands 73
• 5.9 Switzerland 73
  • 5.9.1 Switzerland COVID-19 Cases 73
  • 5.9.2 Switzerland Covid-19 Serology Testing Consumption and Demand 74
  • 5.9.3 Key Covid-19 Serology Testing Approved in Switzerland 74
• 5.10 Russia 75
  • 5.10.1 Russia COVID-19 Cases 75
  • 5.10.2 Russia Covid-19 Serology Testing Consumption and Demand 75
  • 5.10.3 Covid-19 in Russia 76

6 ASIA PACIFIC 77

• 6.1 Asia-Pacific Covid-19 Serology Testing, Total Demand and Consumption by Country, 2020 and 2021 77
• 6.2 China 78
  • 6.2.1 China COVID-19 Cases 78
  • 6.2.2 China Covid-19 Serology Testing Consumption and Demand 79
  • 6.2.3 Key Covid-19 Serology Testing Approved in China 79
• 6.3 Japan 80
  • 6.3.1 Japan COVID-19 Cases 80
  • 6.3.2 Japan Covid-19 Serology Testing Consumption and Demand 80
  • 6.3.3 Covid-19 Serology Testing in Japan 81
• 6.4 South Korea 82
  • 6.4.1 South Korea COVID-19 Cases 82
  • 6.4.2 South Korea Covid-19 Serology Testing Consumption and Demand 83
  • 6.4.3 Key Covid-19 Serology Testing Approved in South Korea 84
• 6.5 India 84
  • 6.5.1 India COVID-19 Cases 84
  • 6.5.2 India Covid-19 Serology Testing Consumption and Demand 85
  • 6.5.3 Covid-19 Serology Testing Products Approved in India 86
• 6.6 Philippines 87
  • 6.6.1 Philippines COVID-19 Cases 87
  • 6.6.2 Philippines Covid-19 Serology Testing Consumption and Demand 87
  • 6.6.3 Covid-19 Serology Testing Products Approved in Philippines 87
• 6.7 Malaysia 88
  • 6.7.1 Malaysia COVID-19 Cases 88
  • 6.7.2 Malaysia Covid-19 Serology Testing Consumption and Demand 88
  • 6.7.3 Covid-19 Serology Testing Products Approved in Malaysia 89
• 6.8 Australia 89
  • 6.8.1 Australia COVID-19 Cases 89
  • 6.8.2 Australia Covid-19 Serology Testing Consumption and Demand 90
  • 6.8.3 Key Covid-19 Serology Testing Products Approved in Australia 90

7 SOUTH AMERICA 92

• 7.1 South America Covid-19 Serology Testing, Total Demand and Consumption by Country, 2020 and 2021 92
• 7.2 Brazil 93
  • 7.2.1 Brazil COVID-19 Cases 93
  • 7.2.2 Brazil Covid-19 Serology Testing Consumption and Demand 93
  • 7.2.3 Covid-19 in Brazil 94
• 7.3 Peru 94
  • 7.3.1 Peru COVID-19 Cases 94
  • 7.3.2 Peru Covid-19 Serology Testing Consumption and Demand 95
  • 7.3.3 Covid-19 in Peru 95
• 7.4 Chile 96
  • 7.4.1 Chile COVID-19 Cases 96
  • 7.4.2 Chile Covid-19 Serology Testing Consumption and Demand 96
  • 7.4.3 Covid-19 in Chile 97

8 MIDDLE EAST AND AFRICA 98

• 8.1 Middle East and Africa Covid-19 Serology Testing, Total Demand and Consumption by Country, 2020 and 2021 98
• 8.2 Iran 99
  • 8.2.1 Iran COVID-19 Cases 99
  • 8.2.2 Iran Covid-19 Serology Testing Consumption and Demand 99
  • 8.2.3 Covid-19 in Iran 99
• 8.3 Israel 100
  • 8.3.1 Israel COVID-19 Cases 100
  • 8.3.2 Israel Covid-19 Serology Testing Consumption and Demand 100
  • 8.3.3 Covid-19 in Israel 101
• 8.4 Saudi Arabia 101
  • 8.4.1 Saudi Arabia COVID-19 Cases 101
  • 8.4.2 Saudi Arabia Covid-19 Serology Testing Consumption and Demand 101
  • 8.4.3 Covid-19 in Saudi Arabia 102
• 8.5 Turkey 102
  • 8.5.1 Turkey COVID-19 Cases 102
  • 8.5.2 Turkey Covid-19 Serology Testing Consumption and Demand 103
  • 8.5.3 Covid-19 Serology Testing in Turkey 103

9 KEY FINDINGS IN THIS REPORT 105

10 APPENDIX 106

• 10.1 Research Methodology 106
  • 10.1.1 Methodology/Research Approach 106
  • 10.1.2 Data Source 109
• 10.2 Disclaimer 112